(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer

NCT05607004 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

87

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Neoplasms
Invasive Breast Cancer
Estrogen-receptor-positive Breast Cancer
HER2-negative Breast Cancer

Interventions

DRUG: (Z)-endoxifen
DRUG: goserelin

Sponsor

Atossa Therapeutics, Inc.

Collaborators

[object Object]